Acute Otitis Media Treatment Market Value to Worth Over US$ 3,200.5 Million at 5.1% CAGR Growth Rate by 2025
SEATTLE, March 17, 2021, (PHARMIWEB) — Acute Otitis Media Treatment Market – Insights
Acute otitis media (AOM) is a painful ear infection that occurs when the area behind eardrum becomes inflated and infected. This leads to severe pain in ear, loss of appetite, fever, nausea, etc. AOM is a most common ear infections among children as the Eustachian tube is shorter as compared to adults, which makes it more accessible to bacteria and viruses. Bacteria such as Streptococcus pneumoniae (strep) and Hemophilus influenzae (H. flu) account for around 85% of cases of AOM and viruses account for only 15% of these cases.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/1333
Market Dynamics
Increasing prevalence of AOM disease is expected to drive growth of the acute otitis media treatment market
Growing prevalence of AOM disease is expected to propel growth of the global acute otitis media treatment market during the forecast period. According to a research published in South African Medical Journal in 2014, global incidence rate of acute otitis media is 10.9% and it was estimated that 80% of children will have at least one episode of acute otitis media (AOM) before the age of 3. Furthermore, according to a study published in Formulary Journal in 2014, AOM accounted for healthcare expenditure of around US$ 314 per child per year in the U.S. which is additional US$ 2.88 billion healthcare expenditure. Moreover, strict policies and recommendations in terms of treatment of AOM for children suggested by various non-governmental and governmental bodies is expected to drive the market growth over the forecast period. For instance, in 2013, the American Academy of Pediatrics (AAP) updated the guidelines for treatment of AOM. AAP launched ‘The Diagnosis and Management of Acute Otitis Media’, in 2013, which provides recommendations to physicians for managing uncomplicated AOM in children. As compared to previous guideline published in 2004, the new guideline has added more criteria for diagnosing AOM. This update in guideline is expected to help in better diagnosis and higher treatment rate, which may boost growth of the global acute otitis media treatment market.
The global acute otitis media treatment market was valued at US$ 1,943.9 million in 2016 and is expected to witness a CAGR of 5.1% over the forecast period (2017–2025).
Figure 1. Global Acute Otitis Media Treatment Market Share (%), By Region, 2017–2025
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://bit.ly/30Slcy0
Launch of novel drugs is expected to support growth of acute otitis media treatment market in the near future
Introduction of novel medications and treatment options by market players is expected to drive the global acute otitis media treatment market growth during the forecast period. For instance, in 2016, Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC launched its OTOVEL (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %). This solution is indicated for the treatment of acute otitis media with tympanostomy tubes (AOMT) in pediatric patients. Moreover, in 2016, Otonomy, Inc. launched its OTIPRIO (ciprofloxacin otic suspension), indicated for the treatment of pediatric patients with bilateral acute otitis media in the U.S.
Market Dynamics- Restraints
Presence of generic drugs at much lower price compared to branded drugs, for the treatment of acute otitis media is expected to restrain growth of the global acute otitis media treatment market in the near future.
Competitive Landscape
Furthermore, key players manufacturing drugs for treatment of acute otitis media are adopting various growth strategies such as product launch and product approvals, in order to gain competitive edge in the market. For instance, in 2013, Alcon launched its DROPS101 Web Tools, a mobile website that provides educational resource about commonly prescribed eye and ear treatments. DROPS101 Web Tools offers product information related to the treatment of acute otitis media. Furthermore, in 2015, Aurobindo Pharma Ltd. received the U.S. Food and Drug Administration (FDA) approval to launch its generic antibiotic Cefixime in the U.S. market. Cefixime is a third generation cephalosporin indicated for the treatment of acute otitis media.
Key players operating in the global acute otitis media treatment market are Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/acute-otitis-media-treatment-market-to-surpass-us-32005-million-threshold-by-2025-618
Table of Contents
- Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Formulation
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Technological Trends
- Unmet Needs
- Regulatory Scenario
- Recent Product Approvals/Launch
- Technological Advancement
- PEST Analysis
- Porter’s Five Forces Analysis
- Market Dynamics
- Global Acute Otitis Media Treatment Market, By Drug Type, 2016–2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Antibiotics
- Nonsteroidal anti-Inflammatory drug
- Analgesic
- Anaesthetic
- Introduction
- Global Acute Otitis Media Treatment Market, By Formulation, 2017–2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Oral
- Topical
- Introduction
- Global Acute Otitis Media Treatment Market, By Distribution Channel, 2016–2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Hospital
- Retail pharmacie
- Online pharmacies
- Introduction
- Global Acute Otitis Media Treatment Market, By Region, 2016–2025 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, For Regions, 2016–2025
- North America
- Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of APAC
- Latin America
- Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
